A dynamic view of mHLA-DR expression in management of severe septic patients.
about
Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change?Immunological monitoring to prevent and treat sepsisPotentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.Increases in inflammatory and CD14dim/CD16pos/CD45pos patrolling monocytes in sepsis: correlation with final outcome.Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study.
P2860
A dynamic view of mHLA-DR expression in management of severe septic patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A dynamic view of mHLA-DR expression in management of severe septic patients.
@ast
A dynamic view of mHLA-DR expression in management of severe septic patients.
@en
type
label
A dynamic view of mHLA-DR expression in management of severe septic patients.
@ast
A dynamic view of mHLA-DR expression in management of severe septic patients.
@en
prefLabel
A dynamic view of mHLA-DR expression in management of severe septic patients.
@ast
A dynamic view of mHLA-DR expression in management of severe septic patients.
@en
P2860
P356
P1433
P1476
A dynamic view of mHLA-DR expression in management of severe septic patients
@en
P2093
Alain Lepape
Guillaume Monneret
P2860
P2888
P356
10.1186/CC10452
P577
2011-10-17T00:00:00Z
P5875
P6179
1024267549